Presentation Information
[JEL02-01]Reconsidering Radium-223 therapy in the Lu-PSMA era: Patient selection and strategy
Norihito Akatani (Department of Nuclear Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University)